Gibson Dunn Shortlisted for Six LMG Life Sciences 2024 Awards Americas

July 23, 2024

Gibson Dunn is shortlisted for six awards at the 2024 LMG Life Sciences Americas Awards. The firm is shortlisted for Corporate Firm of the Year and General Patent Litigation Firm of the Year. Jane Love was shortlisted for General Patent Litigator of the Year – New York; Ryan Murr for M&A Attorney of the Year; Eric Stock for Antitrust Attorney of the Year; and Betty Yang for General Patent Litigator of the Year – South.

The awards ceremony “recognizes the region’s most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.” Winners will be announced at the awards ceremony in New York City on Thursday, September 5, 2024.

The Life Sciences Practice Group represents and advises innovative biotechnology, pharmaceutical and medical device companies on a wide range of legal, regulatory and strategic issues, including patent and product liability litigation, U.S. Food and Drug Administration (FDA) investigations and enforcement actions, and corporate transactions and financings.